Nivolumab+ipilimumab for first-line treatment of malignant pleural mesothelioma
Topic: Developments in Compensation for Mesothelioma: Immunotherapy and Home Renovation Cases
Receive the latest information about the International Mesothelioma Interest Group Meeting 2020 by entering your information below.
Now you will receive all the latest conference updates straight in your mailbox.